BridgeBio Pharma Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $936.0M
Liabilities Breakdown FY2025
Total Liabilities: $3.01B
Asset Breakdown
Total Assets: $936.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $570.1M | 60.9% |
| Accounts Receivable | $139.4M | 14.9% |
| Inventory | $26.8M | 2.9% |
| Property, Plant & Equipment | $5.4M | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $28.1M | 3.0% |
| Other Assets | $166.3M | 17.8% |
Liabilities Breakdown
Total Liabilities: $3.01B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $36.2M | 1.2% |
| Long-Term Debt | $2.01B | 66.6% |
| Other Liabilities | $969.0M | 32.2% |